| Immunisation | ITNs | Anti-malaria drugs | ANC | Child-birth | ARVs | FP | TB |
---|---|---|---|---|---|---|---|---|
 | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) |
Expenditures by urban-rural residence | ||||||||
Urban | 56.2 (180.5) | 0 (0) | 613.3 (2,214.2) | 71.5 (411.6) | 443.6 (3,160.0) | 0 (0) | 0 (0) | 0 (0) |
Rural | 125.0 (320.9) | 22.8 (205.3) | 168.1 (407.8) | 566.4 (2,518.7) | 728.6 (4,779.3) | 0 (0) | 0 (0) | 25.9 (172.6) |
Kruskal-Wallis (p-value) | 117.2 (.0001) | 22.3 (.0001) | 8.3 (.004) | 30.5 (.0001) | 2.6 (0.11) | - | - | 17.1 (.0001) |
Expenditures by Gender | ||||||||
Male | 84.7 (245.6) | 0 (0) | 371.8 (738.6) | NA | NA | 0 (0) | 0 (0) | .80 (12.0) |
Female | 70.1 (221.5) | 5.5 (100.9) | 630.6 (2,479.2) | NA | NA | 0 (0) | 0 (0) | 5.6 (83.7) |
Kruskal-Wallis (p-value) | 6.5 (.01) | 2.3 (.12) | 0.3 (.59) | 25.3 (.0001) | 16.4 (.0001) | - | - | 0.02 (.90) |
Expenditures by SES | ||||||||
Quintile 1 | 73.7 (200.2) | .29 (2.43) | 197.05 (441.5) | 380.7 (1,379.0) | 206.1 (858.1) | 0 (0) | 0 (0) | 2.7 (22.2) |
Quintile 2 | 69.6 (191.7) | .95 (9.8) | 373.49 (1,107.8) | 48.1 (322.9) | 490.2 (3,177.9) | 0 (0) | 0 (0) | 21.0 (160.9) |
Quintile 3 | 108.5 (291.5) | .44 (4.7) | 358.25 (691.1) | 261.1 (2,135.8) | 531.3 (4,312.5) | 0 (0) | 0 (0) | 0 (0) |
Quintile 4 | 56.5 (232.8) | 11.83 (153.9) | 691.12 (3,275.4) | 142.7 (626.7) | 573.7 (3,325.0) | 0 (0) | 0 (0) | 0 (0) |
Quintile 5 | 74.5 (222.9) | .00 (.00) | 773.7 (1,883.1) | 51.5 (278.6) | 476.9 (3,735.0) | 0 (0) | 0 (0) | 0 (0) |
Kruskal-Wallis (p-value) | 19.5 (.0006) | 2.0 (0.73) | 9.0 (.06) | 15.6 (.004) | 0.68 (.095) | - | - | 7.9 (.09) |
Concentration index | −0.10 | 0.13 | 0.13 | −0.41 | −0.08 | - | - | −0.45 |
Total | 75.6 (230.7) | 3.5 (80.4) | 535.7 (2,026.0) | 150.97 (1,088.8) | 485.8 (3,444.4) | 0 (0) | 0 (0) | 3.9 (67.1) |